Drug intelligence / Profile preview

alpha-melanocyte stimulating hormone

Development stage
Phase 1
Modality
Recombinant Proteins and Enzymes, Peptides
01

Overview

Alpha-melanocyte stimulating hormone (α-MSH) is an endogenous tridecapeptide hormone and neuropeptide of the melanocortin family. It is produced primarily in the anterior pituitary gland but also in the skin and hypothalamus. Derived from pro-opiomelanocortin (POMC), α-MSH plays a central role in stimulating melanogenesis—the production of melanin by melanocytes—leading to pigmentation of skin, hair, and eyes. Beyond pigmentation, α-MSH regulates appetite and energy homeostasis via action on hypothalamic receptors; it also influences sexual behavior, exerts anti-inflammatory effects, modulates immune responses, and provides protection against ischemia-reperfusion injury. Its biological actions are mediated through non-selective full agonism at several melanocortin receptors (MC1R for pigmentation; MC3R/MC4R for appetite/metabolism). Synthetic analogues have been developed as drugs for photoprotection or other indications[7][4][5][6].

Other names
melanotropinα-MSHalpha MSH
02

Targets

MC1R (Melanocortin Type 1 Receptor)MC3R (Melanocortin Receptor Type 3)MC4R (Melanocortin 4 receptor)MC5R (Melanocortin 5 Receptor)

Beyond the preview

Go deeper on alpha-melanocyte stimulating hormone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-melanocyte stimulating hormone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call